Pura Vida Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Pura Vida Investments’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,985	Closed	-$1.3M	–	299
2022 Q1	$1.3M	Buy	10,985 +100	+0.9%	+$12.5K	0.04%	179
2021 Q4	$1.5M	Buy	+10,885	New	+$1.38M	0.05%	159
2019 Q4	–	Sell	-40,000	Closed	-$1.98M	–	141
2019 Q3	$1.67M	Buy	+40,000	New	+$1.69M	0.29%	70
2019 Q2	–	Sell	-30,000	Closed	-$1.69M	–	143
2019 Q1	$1.54M	Buy	+30,000	New	+$1.3M	0.22%	86
2018 Q2	–	Sell	-32,186	Closed	-$829K	–	127
2018 Q1	$829K	Sell	32,186 -10,000	-24%	-$299K	0.49%	48
2017 Q4	$1.14M	Buy	+42,186	New	+$1.16M	0.48%	55

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pura Vida Investments's BHVN Position: Q2 2022 in Review

Pura Vida Investments sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2022, closing a stake of 10,985 shares — an estimated $1.3M sold.

Pura Vida Investments first reported a position in BHVN in Q4 2017 and held it in 6 quarters. The position peaked at $1.67M in Q3 2019. 329 funds tracked by Wall St. Rank hold BHVN as of Q2 2022.

Pura Vida Investments reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2022 after selling out during the quarter.
Pura Vida Investments sold 10,985 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2022, an estimated $1.3M.
Pura Vida Investments first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and held it in 6 quarters.
Pura Vida Investments's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.67M in Q3 2019.
329 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.